Medical history made as surgeons successfully restore sight to legally blind patient using world's first 3D printed corneal ...
Patients treated with 0.05% urcosimod demonstrated directionally favorable improvements in nerve fiber count and fiber length ...
TipRanks on MSN
OKYO Pharma reports positive phase 2 results for Urcosimod in neuropathic corneal pain
The latest announcement is out from OKYO Pharma Limited Sponsored ADR ( ($OKYO) ). On December 11, 2025, OKYO Pharma Limited ...
Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...
It looks like an ordinary contact lens, but when exposed to near-infrared light, it emits the ultraviolet light used for ...
West Des Moines, Iowa – December 11, 2025 – PRESSADVANTAGE – In Modern Vision Center’s new article, Dr. Drew Dickson: Des ...
Okyo Pharma (OKYO) announced new analyses of corneal images from the recently completed Phase 2 clinical trial of urcosimod in neuropathic corneal ...
Modern Vision Centers has released a new article titled “The Truth About EVO ICL and Glare: What Research Actually Shows,” addressing one of the most common questions patients have about implantable ...
Air pollution is causing rising eye problems in India. Learn how smog harms the eyes, the symptoms to watch for, and simple ...
Optometrist, clinic supervisor at Aston University, and Alcon professional education faculty member, Hatim Hassanali, shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback